Nox4 and Vascular Homeostasis
Nox4 和血管稳态
基本信息
- 批准号:8759579
- 负责人:
- 金额:$ 47.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-15 至 2018-06-30
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelAnimalsAntioxidantsArteriesBlood VesselsBlood coagulationBone Marrow TransplantationCell Culture TechniquesCell modelChemicalsDataDrug or chemical Tissue DistributionElementsEndothelial CellsEnzymesExerciseExercise stress testFamilyFamily memberFunctional disorderFundingGene Expression RegulationGenetic ModelsHandHealthHematopoieticHomeostasisHost DefenseHumanHydrogen PeroxideInjuryInvadedKnock-outKnowledgeModelingMolecularMusNADPH OxidaseNormal CellOrganismPathway interactionsPhysiologicalPhysiologyPlayProtein IsoformsProtocols documentationReactive Oxygen SpeciesRegulationResearchResistanceRoleShunt DeviceSignal PathwaySignal TransductionSkeletal MuscleSmooth MuscleSolidSourceStressSuperoxidesSystemTestingThrombomodulinThrombosisTissuesTubeUp-RegulationVascular DiseasesWild Type MouseWorkWound Healingadenylate kinasecell killingcell typeimproved functioningin vivoinsightinterestkillingsloss of functionpreventpublic health relevanceresearch studyresponsesuperoxide-generating NADPH oxidasetherapy designtissue repair
项目摘要
DESCRIPTION (provided by applicant): Reactive oxygen species (ROS) include superoxide and its downstream metabolites. These species are known to play multiple roles in both physiology and pathophysiology. A prominent source of ROS in vivo are the NADPH oxidase (Nox) family of enzymes that in humans consists of 7 isoforms (Nox1-5, Duox1, Duox2) with distinct tissue distribution and mechanisms of regulation. The prototypic family member (Nox2) is the classic "respiratory burst oxidase' that produces high levels of ROS under strict regulation
that are critical for host defence. ROS important in cellular signaling are produced at more modest levels, often by other Nox isoforms, and have been described in other cell types. In this regard, the Nox4 NADPH oxidase isoform is of particular interest as it constitutively generates ROS in the form of hydrogen peroxide (H2O2) and is regulated principally at the transcriptional level. Emerging data from our previous funding period indicate that Nox4, in contrast to ¿O2- producing NADPH oxidase isoforms, promotes physiological vascular adaptation and tissue repair. In this application, we present data supporting our central hypothesis that endothelial Nox4 is required for the adaptive vascular effects of endurance exercise including enhanced NO¿ bioactivity and thrombosis resistance. To investigate this hypothesis, we will first determine the in vivo role of Nox4 in the vascular response to endurance exercise. For these studies, Nox4-/- and wild-type mice will undergo endurance exercise followed by assessment of vascular adaptation determined as eNOS/NO¿ bioactivity, and upregulation of antithrombotic (KLF2, thrombomodulin) and antioxidant (Nrf2, PGC-1¿) pathways. To determine the specific impact of endothelial Nox4, we will also test exercise-induced vascular adaptation in constitutive and inducible endothelial- specific Nox4 knockout (ECKONox4) models we have created and characterized. We will then determine the role of antioxidant gene regulation in the Nox4 response to endurance exercise as our preliminary data indicate that Nox4 upregulates both Nrf2- and PGC-1¿-dependent pathways in the vasculature. Accordingly we will perform our exercise protocol on global (Nrf2-/-, PGC-1¿-/-) and endothelial-specific loss-of-function models (ECKONrf2, ECKOPGC-1¿), and assess the pathways outlined above in Aim1. We will then determine if PGC-1¿ is sufficient to mimic exercise-induced vascular adaptation with an animal model of endothelial-specifc PGC-1¿ upregulation we have created that features enhanced NO¿ bioactivity. Finally, we will determine the mechanisms regulating Nox4 and its contribution to the endothelial response to endurance exercise. Using an established carotid-to-jugular shunt system, we will model the extent to which increased flow mimics the changes in eNOS/NO¿, antithrombotic activity, and antioxidant activity seen with exercise. We will then test this model n Nox4-/- and ECKONox4 mice and determine the impact on NO¿ bioactivity and the antithrombotic and antioxidant pathways listed above. We will then use human and murine endothelial cell models of Nox4, AMP kinase, Nrf2, and PGC-1¿ manipulation to determine the molecular mechanisms whereby Nox4 dictates the endothelial response to endurance exercise with regards to NO¿ bioactivity, thrombosis resistance, and antioxidant upregulation. The experiments outlined above should provide us with a solid working knowledge of how Nox4 contributes to vascular homeostasis. These data will be a key element of determining how ROS can be adaptive in the vasculature and, importantly, how ROS positively regulate NO¿ bioactivity and thromboresistance. With this information in hand, we should have the requisite insight to design therapies that modulate vascular ROS and better predict their impact on normal vascular physiology and also the pathophysiology of vascular disease.
描述(由申请人提供):活性氧(ROS)包括超氧化物及其下游代谢物,已知这些物质在生理学和病理生理学中发挥多种作用,体内 ROS 的一个重要来源是 NADPH 氧化酶(Nox)家族。人类中由 7 种同工型(Nox1-5、Duox1、Duox2)组成的酶,具有不同的组织分布和调节机制。 (Nox2)是经典的“呼吸爆发氧化酶”,在严格调控下产生高水平的ROS
对宿主防御至关重要的 ROS 通常由其他 Nox 亚型产生,并且已在其他细胞类型中得到描述。在这方面,Nox4 NADPH 氧化酶亚型特别令人感兴趣,因为它是组成型。与此相反,Nox4 以过氧化氢 (H2O2) 的形式产生 ROS,并且主要在转录水平上受到调节。 ¿产生 O2 的 NADPH 氧化酶亚型,促进生理性血管适应和组织修复 在本申请中,我们提供的数据支持我们的中心假设,即内皮 Nox4 是耐力运动的适应性血管效应所必需的,包括增强的 NO¿为了研究这一假设,我们首先确定 Nox4 在耐力运动血管反应中的作用。在这些研究中,Nox4-/- 和野生型小鼠将接受运动,然后评估血管适应。确定为 eNOS/NO¿生物活性以及抗血栓(KLF2、血栓调节蛋白)和抗氧化剂(Nrf2、PGC-1¿)途径的上调为了确定内皮 Nox4 的具体影响,我们还将测试运动诱导的血管适应在组成型和诱导型内皮特异性 Nox4 敲除中。我们创建并表征了 (ECKONox4) 模型,然后我们将确定抗氧化基因调控在 Nox4 对耐力运动的反应中的作用。初步数据表明 Nox4 上调 Nrf2- 和 PGC-1¿因此,我们将在全局(Nrf2-/-、PGC-1¿-/-)和内皮特异性功能丧失模型(ECKONrf2、ECKOPGC-1¿)上执行我们的运动方案,以及评估上述 Aim1 中概述的途径,然后我们将确定 PGC-1¿足以用内皮特异性 PGC-1 动物模型模拟运动诱导的血管适应我们创建的上调功能增强了 NO¿最后,我们将确定调节 Nox4 的机制及其对耐力运动的内皮反应的贡献,我们将模拟 eNOS/NO 变化的流量增加程度。然后,我们将在 Nox4-/- 和 ECKONox4 小鼠中测试该模型,并确定对 NO¿然后我们将使用 Nox4、AMP 激酶、Nrf2 和 PGC-1 的生物活性以及抗血栓和抗氧化途径。操作以确定 Nox4 决定内皮细胞对 NO 耐力运动反应的分子机制上面概述的实验应该为我们提供关于 Nox4 如何促进血管稳态的扎实的工作知识,这些数据将是确定 ROS 如何在脉管系统中适应的关键因素。 ROS 如何积极调节 NO¿有了这些信息,我们应该有必要的洞察力来设计调节血管活性氧的疗法,并更好地预测它们对正常血管生理学和血管疾病病理生理学的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John Francis Keaney其他文献
John Francis Keaney的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John Francis Keaney', 18)}}的其他基金
Telomerase Reverse Transcriptase in Vascular Homeostasis
端粒酶逆转录酶在血管稳态中的作用
- 批准号:
10619665 - 财政年份:2020
- 资助金额:
$ 47.38万 - 项目类别:
Telomerase Reverse Transcriptase in Vascular Homeostasis
端粒酶逆转录酶在血管稳态中的作用
- 批准号:
10412985 - 财政年份:2020
- 资助金额:
$ 47.38万 - 项目类别:
Telomerase Reverse Transcriptase in Vascular Homeostasis
端粒酶逆转录酶在血管稳态中的作用
- 批准号:
10159954 - 财政年份:2020
- 资助金额:
$ 47.38万 - 项目类别:
Role of energy metabolism in the brown fat program
能量代谢在棕色脂肪计划中的作用
- 批准号:
9135635 - 财政年份:2015
- 资助金额:
$ 47.38万 - 项目类别:
Mitochondrial Biogenesis and Endothelial Cell Phenotype
线粒体生物发生和内皮细胞表型
- 批准号:
7581392 - 财政年份:2009
- 资助金额:
$ 47.38万 - 项目类别:
相似国自然基金
基于供应链视角的动物源性食品中抗微生物药物耐药性传导机制及监管策略研究
- 批准号:72303209
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
热带森林土壤氮添加下微节肢动物对氮转化过程的调控
- 批准号:32360323
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
Slc39a13在哺乳动物铁代谢中的作用
- 批准号:32371226
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
乳酸介导的组蛋白乳酸化调控哺乳动物主要合子基因组激活的机制研究
- 批准号:82301880
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
早期环境暴露对儿童哮喘免疫保护的动物实验和机制研究
- 批准号:82300031
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Oxidative Stress and Mitochondrial Dysfunction in Chemogenetic Heart Failure
化学遗传性心力衰竭中的氧化应激和线粒体功能障碍
- 批准号:
10643012 - 财政年份:2023
- 资助金额:
$ 47.38万 - 项目类别:
Developing trimester-specific placenta organ-on-chips to model healthy and oxidative stress and inflammation-associated pathologies
开发妊娠期特异性胎盘器官芯片来模拟健康和氧化应激以及炎症相关的病理学
- 批准号:
10732666 - 财政年份:2023
- 资助金额:
$ 47.38万 - 项目类别:
Synergistically Target Mitochondria for Heart Failure Treatment
协同靶向线粒体治疗心力衰竭
- 批准号:
10584938 - 财政年份:2023
- 资助金额:
$ 47.38万 - 项目类别:
Development of a 3D neurovascular unit for in vitro modeling of subarachnoid hemorrhage and screening therapies
开发用于蛛网膜下腔出血体外建模和筛选治疗的 3D 神经血管单元
- 批准号:
10722387 - 财政年份:2023
- 资助金额:
$ 47.38万 - 项目类别: